CRVO CervoMed Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CRVO

Price (delayed)

$24.06

Market cap

$148.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.82

Enterprise value

$140.67M

diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing ...

Highlights
The debt has plunged by 100% YoY
CervoMed's EPS has surged by 93% YoY and by 88% QoQ
The company's equity has surged by 122% YoY but it fell by 23% QoQ
The company's quick ratio fell by 21% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://diffusionpharma.com/
Peers: OMER OMGA

Key stats

What are the main financial stats of CRVO
Market
Shares outstanding
6.17M
Market cap
$148.46M
Enterprise value
$140.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
18.51
Price to sales (P/S)
8.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.69
Earnings
Revenue
$7.14M
EBIT
-$2.17M
EBITDA
-$2.17M
Free cash flow
-$7.45M
Per share
EPS
-$0.82
Free cash flow per share
-$2.8
Book value per share
$1.3
Revenue per share
$2.68
TBVPS
$3.75
Balance sheet
Total assets
$9.97M
Total liabilities
$2.6M
Debt
$0
Equity
$7.38M
Working capital
$7.37M
Liquidity
Debt to equity
0
Current ratio
3.84
Quick ratio
3.35
Net debt/EBITDA
3.59
Margins
EBITDA margin
-30.4%
Gross margin
100%
Net margin
-30.4%
Operating margin
-109.3%
Efficiency
Return on assets
-15.5%
Return on equity
-18.3%
Return on invested capital
N/A
Return on capital employed
-29.4%
Return on sales
-30.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRVO stock price

How has the CervoMed stock price performed over time
Intraday
-0.33%
1 week
1.01%
1 month
14.41%
1 year
322.11%
YTD
215.33%
QTD
3.26%

Financial performance

How have CervoMed's revenue and profit performed over time
Revenue
$7.14M
Gross profit
$7.14M
Operating income
-$7.81M
Net income
-$2.17M
Gross margin
100%
Net margin
-30.4%
CRVO's operating income has dropped by 125% year-on-year but it is up by 23% since the previous quarter
The net margin has soared by 92% from the previous quarter
The operating margin has soared by 84% from the previous quarter
CRVO's net income has soared by 63% YoY and by 61% QoQ

Growth

What is CervoMed's growth rate over time

Valuation

What is CervoMed stock price valuation
P/E
N/A
P/B
18.51
P/S
8.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.69
CervoMed's EPS has surged by 93% YoY and by 88% QoQ
The company's equity has surged by 122% YoY but it fell by 23% QoQ

Efficiency

How efficient is CervoMed business performance
The return on equity has surged by 94% since the previous quarter and by 62% year-on-year
CervoMed's return on sales has surged by 92% QoQ
The ROA has soared by 65% from the previous quarter and by 38% YoY

Dividends

What is CRVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRVO.

Financial health

How did CervoMed financials performed over time
The company's total assets has surged by 140% YoY but it fell by 17% QoQ
The total liabilities has plunged by 80% YoY but it has grown by 5% from the previous quarter
The debt is 100% less than the equity
The company's equity has surged by 122% YoY but it fell by 23% QoQ
The debt has plunged by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.